Key result
Genotype-guided antiplatelet de-escalation offers a practical management approach post-PCI.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
May support personalized post-PCI antiplatelet strategies; leaves open need for randomized confirmation.
Genotyping may represent a more practical approach to guide de-escalation of antiplatelet
No takes yet. Share an insight, caveat, or question.
Cavallari et al. (2019) studied this question. Genotype-guided de-escalation of antiplatelet therapy may represent a practical approach for managing patients after percutaneous coronary angioplasty.
Synapse has enriched 10 related papers. Consider them for comparative context: